What is Seaport Therapeutics 's net investment in lease?

Seaport Therapeutics (SPTX) reported net investment in lease of $5.07M in Q1 2026.

Seaport Therapeutics SPTX Net Investment in Lease

Net Investment in Lease at other companies

PNC Financial ServicesPNC

$6.64B+6.6%

Wintrust FinancialWTFC

$362.77M+29.3%

WelltowerWELL

$57.8M—

Gaming and Leisure PropertiesGLPI

$250.51M+2.0%

Wells Fargo & CompanyWFC

$1T+11.5%

Regency CentersREG

$16.79M+1.6%

Other financials

Income statement

See full

Operating income-$27.5M-70.2%

Net income-$25.4M-93.6%

EPS (diluted)-$10.34-83.0%

Balance sheet

See full

Cash & equivalents$52.9M—

Total debt$5.3M—

Total equity-$115.6M-220%

Total assets$227.7M—

Cash flow

See full

Operating cash flow-$20.2M+0.2%

CapEx--100%

Free cash flow-$20.2M+0.4%

Valuation

See full

Market cap$972.65M—

Enterprise value$925.08M—

Returns & leverage

See full

Debt / equity-0×—

Current ratio13.2×—

Where this comes from

Reported directly by Seaport Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Seaport Therapeutics ’s 10-Q, filed June 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Seaport Therapeutics 's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Seaport Therapeutics 's net investment in lease?: Seaport Therapeutics (SPTX) reported net investment in lease of $5.07M in Q1 2026.